These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 31710871)

  • 1. Prognostic factors for primary Sjögren's syndrome-associated interstitial lung diseases.
    Kamiya Y; Fujisawa T; Kono M; Nakamura H; Yokomura K; Koshimizu N; Toyoshima M; Imokawa S; Sumikawa H; Johkoh T; Yasui H; Hozumi H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
    Respir Med; 2019 Nov; 159():105811. PubMed ID: 31710871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of interstitial lung disease associated with primary Sjögren's syndrome.
    Weng L; Chen Y; Liang T; Lin Y; Liu D; Yu C; Hu Y; Lui W; Liu Y; Chen X; Li Q; Ge S; Ascherman DP; Chen J
    Eur J Med Res; 2022 Oct; 27(1):199. PubMed ID: 36217184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
    Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
    Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for progression and prognosis of primary Sjögren's syndrome-associated interstitial lung disease in a Chinese population.
    Xu Y; Zhou J; Dong X; Guo X; Lu Y; Zheng Y
    Int J Rheum Dis; 2020 Dec; 23(12):1734-1740. PubMed ID: 33226736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in interstitial lung disease associated with primary Sjögren's syndrome: a retrospective analysis of 33 pathologically-proven cases.
    Enomoto Y; Takemura T; Hagiwara E; Iwasawa T; Fukuda Y; Yanagawa N; Sakai F; Baba T; Nagaoka S; Ogura T
    PLoS One; 2013; 8(9):e73774. PubMed ID: 24040065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjögren's syndrome-related interstitial lung disease in a Chinese population.
    Dong X; Zhou J; Guo X; Li Y; Xu Y; Fu Q; Lu Y; Zheng Y
    Clin Rheumatol; 2018 Nov; 37(11):2981-2988. PubMed ID: 30242640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes of serum Krebs von den Lungen-6 levels in interstitial lung disease associated with dermatomyositis and secondary Sjögren's syndrome: a case report].
    Yu JF; Jin YB; He J; An Y; Li ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):910-914. PubMed ID: 29045979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Serum Krebs von den Lungen-6 in Early Disease Predicts Subsequent Deterioration of Pulmonary Function in Patients with Systemic Sclerosis and Interstitial Lung Disease.
    Kuwana M; Shirai Y; Takeuchi T
    J Rheumatol; 2016 Oct; 43(10):1825-1831. PubMed ID: 27481907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of blood KL-6 in rheumatoid arthritis-associated interstitial lung disease.
    Kim HC; Choi KH; Jacob J; Song JW
    PLoS One; 2020; 15(3):e0229997. PubMed ID: 32163457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Krebs von den Lungen-6 level predicts disease progression in interstitial lung disease.
    Ko UW; Cho EJ; Oh HB; Koo HJ; Do KH; Song JW
    PLoS One; 2020; 15(12):e0244114. PubMed ID: 33332430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood KL-6 predicts prognosis in primary Sjögren's syndrome-associated interstitial lung disease.
    Kim YJ; Choe J; Moon SJ; Song JW
    Sci Rep; 2022 Mar; 12(1):5343. PubMed ID: 35351939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease.
    Elhai M; Hoffmann-Vold AM; Avouac J; Pezet S; Cauvet A; Leblond A; Fretheim H; Garen T; Kuwana M; Molberg Ø; Allanore Y
    Arthritis Rheumatol; 2019 Jun; 71(6):972-982. PubMed ID: 30624031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of patients with primary Sjögren's syndrome associated interstitial lung disease and relevant features of disease progression.
    Zhang T; Yuan F; Xu L; Sun W; Liu L; Xue J
    Clin Rheumatol; 2020 May; 39(5):1561-1568. PubMed ID: 31902032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical course and outcome in patients with primary Sjögren syndrome-associated interstitial lung disease.
    Kim YJ; Choe J; Kim HJ; Song JW
    Sci Rep; 2021 Jun; 11(1):12827. PubMed ID: 34145316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial lung disease in primary Sjögren's syndrome.
    Roca F; Dominique S; Schmidt J; Smail A; Duhaut P; Lévesque H; Marie I
    Autoimmun Rev; 2017 Jan; 16(1):48-54. PubMed ID: 27682894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and risk factors for primary Sjögren's syndrome combined with interstitial lung disease: a retrospective study.
    Yang Z; Zhao H; Shan L; Wang D
    Acta Biochim Pol; 2024; 71():12461. PubMed ID: 38721305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiopoietin-like protein 2 as a novel marker for patients with primary Sjogren's syndrome-related interstitial lung disease.
    Shi L; Fu Q; Chen N; Liu R; Zheng Y
    Clin Exp Med; 2020 Aug; 20(3):393-399. PubMed ID: 32253547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Clinical Value of KL-6 and Tumor Markers in Primary Sjögren's Syndrome Complicated with Interstitial Lung Disease.
    Wei F; Zhang X; Yang S; Geng J; Xie B; Ren Y; Dai H
    J Clin Med; 2023 Jul; 12(15):. PubMed ID: 37568332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for progression of interstitial lung disease in Sjögren's syndrome: a single-centered, retrospective study.
    He SH; He YJ; Guo KJ; Liang X; Li SS; Li TF
    Clin Rheumatol; 2022 Apr; 41(4):1153-1161. PubMed ID: 34757493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic changes in serum KL-6 levels predict disease progression in patients with systemic sclerosis-associated interstitial lung disease.
    Watanabe S; Kase K; Saeki K; Ohkura N; Murata A; Waseda Y; Takato H; Ichikawa Y; Yasui M; Kasahara K
    Respir Med; 2022 Jan; 191():106689. PubMed ID: 34844174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.